The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

Robert P. Hebbel, G. Vercellotti, SB Pace, AN Solovey , R Kollander , Chinemerem (Fred) Abanonu, J Nguyen , JV Vineyard, JD Belcher, F Abdulla , S Osifuye, JW Eaton, RJ Jr Kelm, A Slungaard

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)
Original languageEnglish (US)
Pages (from-to)2483-90
JournalBlood
Volume115
Issue number12
StateAccepted/In press - Mar 25 2010

Cite this